Can-Fite Biopharma Ltd ADR (CANF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 165 | 0 | 0 | 0 | 500 |
| Gross Profit | 165 | 0 | 0 | N/A | 500 |
| Operating Expenses | 6,583 | 7,130 | 9,010 | 0 | 5,590 |
| Operating Income | -6,418 | -7,130 | -9,010 | N/A | -5,090 |
| Interest Expense | 564 | 310 | 60 | 0 | 60 |
| Other Income | 1,920 | 1,140 | 200 | 0 | -2,760 |
| Pre-tax Income | -5,062 | -6,300 | -8,870 | 0 | -7,910 |
| Income Tax | 4 | 6 | 3 | N/A | 50 |
| Net Income Continuous | -5,066 | -6,571 | -8,369 | N/A | -7,145 |
| Minority Interests | -267 | N/A | N/A | N/A | N/A |
| Net Income | $-4,799 | $-6,300 | $-8,870 | $N/A | $-7,960 |
| EPS Basic Total Ops | -1,259.37 | -2,098.95 | -3,658.17 | N/A | -5,067.47 |
| EPS Basic Continuous Ops | -1,329.46 | -2,119.68 | -3,638.70 | N/A | -5,103.57 |
| EPS Diluted Total Ops | -1,259.37 | -2,098.95 | -3,658.17 | N/A | -5,037.48 |
| EPS Diluted Continuous Ops | -1,329.46 | -2,119.68 | -3,638.70 | N/A | -5,103.57 |
| EBITDA(a) | $-6,402 | $-7,130 | $-9,000 | $N/A | $-5,030 |